Patents Examined by Patricia Mallari
  • Patent number: 10010266
    Abstract: A medical mouthpiece may include a U-shaped first member having a tubular portion, the first member forming at least one lateral interocclusal passageway extending through the first member, and a second member received within the tubular portion. A medical breathing apparatus may include a U-shaped first member forming left and right lateral interocclusal passageways extending through the first member, a second member attached to the first member, and an adapter receivable within a tubular portion of the first member, wherein the adapter includes a respiratory orifice configured to deliver respiratory gas to the left and right lateral interocclusal passageways. A method for delivering positive pressure and/or a respiratory gas to a patient may include inserting a mouthpiece into a mouth of the patient, and delivering the positive pressure and/or the respiratory gas through the mouthpiece to a space adjacent a posterior oropharynx of the patient.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: July 3, 2018
    Assignee: AIRWAY CONTROL TECHNOLOGIES, LLC
    Inventors: Timothy Hestness, Robert Moore
  • Patent number: 10010264
    Abstract: Systems and methods for quantifying the likelihood of the contribution of multiple possible forms of chronic disease to patient reported dyspnea can include the testing protocol having a flow/volume loop, performed at rest, flowed by the measurement of cardiopulmonary exercise gas exchange variables during rest, exercise and recovery as unique data sets. The data sets are analyzed using feature extraction steps to produce a pictorial image consisting of disease silos displaying the likelihood of the contribution of various chronic diseases to patient reported dyspnea. In some embodiments, the silos are split into subclass silos. In some embodiments, multiple chronic disease indexes are used to differentiate between sub-types of a particular chronic disease (e.g., differentiating WHO 1 PH from WHO 2 or WHO 3 PH). Test results are plotted serially to asses to provide feedback to the physician on the efficacy of therapy provided to the patient.
    Type: Grant
    Filed: July 25, 2014
    Date of Patent: July 3, 2018
    Assignee: Shape Medical Systems, Inc.
    Inventors: Stephen T. Anderson, Dean J. MacCarter, David M. Anderson, Andrew Hofmeister
  • Patent number: 10010275
    Abstract: An introducer is provided for introducing a sensor into the body of a patient. The introducer connects to a sensor hub. When the sensor hub and introducer are connected, the introducer needle is exposed. When the sensor hub and introducer are disconnected, a needle cover and the needle move with respect to each other so that the needle cover substantially covers the needle, protecting a user from being injured by the needle.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: July 3, 2018
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Rebecca K. Gottlieb, Rajiv Shah, Katherine T. Wolfe, Eric Allan Larson
  • Patent number: 10004434
    Abstract: A sensing device, designed to be used in contact with the skin, contains a plurality of individually controllable sites for electrochemically monitoring an analyte, such as glucose, in interstitial fluid of a user. The device includes at least a hydrophobic layer designed to contact the skin; a capillary channel providing an opening adjacent the skin; a metal electrode layer having a sensor layer applied to an edge portion thereof such that it is exposed to the interior of said capillary channel, the sensing layer being effective to measure the analyte.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: June 26, 2018
    Assignee: Georgetown University
    Inventor: Makarand Paranjape
  • Patent number: 9993208
    Abstract: Present embodiments are directed to a system and method capable of detecting and graphically indicating physiologic patterns in patient data. For example, present embodiments may include a monitoring system that includes a monitor capable of receiving input relating to patient physiological parameters and storing historical data related to the parameters. Additionally, the monitoring system may include a screen capable of displaying the historical data corresponding to the patient physiological parameters. Further, the monitoring system may include a pattern detection feature capable of analyzing the historical data to detect a physiologic pattern in a segment of the historical data and capable of initiating a graphical indication of the segment on the screen when the physiologic pattern is present in the segment.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: June 12, 2018
    Assignee: Covidien LP
    Inventors: Keith Batchelder, Scott Amundson, Mark Brecht
  • Patent number: 9987452
    Abstract: A ventilation analysis system comprising an interface module adapted to receive a carbon dioxide (CO2) signal and a breath flow dynamics signal, and control logic adapted to produce a ventilation indicator, based on a mutual analysis of the CO2 signal and the breath flow dynamics signal. The ventilation indicator may be, for example, an estimated CO2 waveform, an End-Tidal CO2 (ETCO2) value, and/or a minute CO2 value.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: June 5, 2018
    Assignee: ORIDION MEDICAL 1987 LTD.
    Inventors: Joshua Lewis Colman, Zion Botesazan
  • Patent number: 9986918
    Abstract: Systems and methods to indicate heart failure co-morbidity are described. In an example, one or more physiological signals can be analyzed for a specified time period to determine at least one of an indication of a heart failure event or a characteristic of heart failure co-morbidity, such as a characteristic of a non-heart failure physiological event. At least one of the different physiological signals can be compared to a specified criterion indicative of the heart failure event to provide a comparison value, where the comparison value is indicative of whether the at least one of the different physiological signals contributed towards the indication of the heart failure event. An indication of a non-heart failure physiological event can be determined using the heart failure event indication, the non-heart failure physiological event characteristic, and the comparison value indicative of whether the one or more physiological signals contributed towards the heart failure event.
    Type: Grant
    Filed: February 29, 2012
    Date of Patent: June 5, 2018
    Assignee: Cardiac Pacemakers, Inc.
    Inventor: Robert J. Sweeney
  • Patent number: 9984584
    Abstract: Systems and methods for brain stimulation.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: May 29, 2018
    Assignee: Lotus Magnus, LLC
    Inventors: Timothy Walter, Uma Marar
  • Patent number: 9980670
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte, such as blood glucose. An inserter having a retractable introducer is provided for subcutaneously implanting the sensor in a predictable and reliable fashion.
    Type: Grant
    Filed: April 3, 2014
    Date of Patent: May 29, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Jeffery V. Funderburk, Duane O. Yamasaki, Brian VanHiel, Stephen J. Flynn, Bradley D. Kelemen
  • Patent number: 9980669
    Abstract: Methods and devices for providing application specific integrated circuit architecture for a two electrode analyte sensor or a three electrode analyte sensor are provided. Systems and kits employing the same are also provided.
    Type: Grant
    Filed: November 7, 2012
    Date of Patent: May 29, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Jean-Pierre Cole, Martin J. Fennell
  • Patent number: 9976978
    Abstract: A sensor system includes a sensor and a sensor electronics device. The sensor includes a plurality of electrodes. The sensor electronics device includes a connection detection device, a power source, and a delay circuit. The connection detection device determines if the sensor electronics device is connected to the sensor and transmits a connection signal. The delay circuit receives the connection signal, waits a preset hydration time, and couples the regulated voltage from the power source to an electrode in the sensor after the preset hydration time has elapsed. Alternatively, the sensor electronics device may include an electrical detection circuit and a microcontroller. The electrical detection circuit determines if the plurality of electrodes are hydrated and generates an interrupt if the electrodes are hydrated. A microcontroller receives the interrupt and transmits a signal representative of a voltage to an electrode of the plurality of electrodes.
    Type: Grant
    Filed: July 3, 2017
    Date of Patent: May 22, 2018
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Rajiv Shah, Wayne A. Morgan, David Y. Choy, James L. Henke, Bahar Reghabi, Gopikrishnan Soundararajan, Peter Schultz, Udo Hoss
  • Patent number: 9974450
    Abstract: A method for determining a calibrated aortic pressure waveform from a brachial cuff waveform involves the use of one or more generalized transfer functions. The one or more generalized transfer functions are specific for predetermined brachial cuff pressure ranges, such as below diastolic pressure, between diastolic and systolic pressure, and above systolic pressure. The brachial cuff is inflated to a pressure within the pressure range appropriate for the generalized transfer function to be applied to the brachial cuff waveform to generate the aortic pressure waveform. In some circumstances, it may be necessary to use a calibration transfer function to generate a calibrated aortic waveform. In other circumstances, the calibration transfer function is not necessary.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: May 22, 2018
    Assignee: ATCOR MEDICAL PTY LTD
    Inventor: Ahmad M. Qasem
  • Patent number: 9968281
    Abstract: A breath condensate collector (10) comprising a chamber having a breath inlet port (14) and an outlet port (16); a sample collector, adapted to receive breath from the chamber outlet and having air exhaust means; cooling means (112) to promote in use condensation of vapor from breath entering the sample collector and where collector comprises a partially lidded dish (110).
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: May 15, 2018
    Assignee: Exhalation Technology Ltd
    Inventor: George Lee Bulbrook
  • Patent number: 9955899
    Abstract: A respiratory waveform analyzer, operable to analyze a respiratory waveform, which is generated based on a temporal change of a concentration of a component in respiratory gas of a subject, includes: a respiratory gas concentration generator which generates a concentration signal based on an output signal from a sensor that is placed to measure the concentration of the component; a flatness calculator which calculates a flatness indicative of flat degree of the respiratory waveform based on a temporal change of the concentration signal; and a reliability calculator which calculates a reliability of the respiratory waveform based on the flatness and the concentration signal.
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: May 1, 2018
    Assignee: NIHON KOHDEN CORPORATION
    Inventors: Toshiki Aoki, Hidetoshi Dainobu, Teiji Ukawa, Masahiro Echigo
  • Patent number: 9949668
    Abstract: A method involves implantably detecting changes in posture of a patient's body. Baroreflex responses to the posture changes are determined. An autonomic tone of the patient is determined based on the baroreflex responses. Based on the autonomic tone, various patient susceptibilities to disease may be determined, including susceptibilities to heart disease, arrhythmia, and/or sudden cardiac death.
    Type: Grant
    Filed: February 7, 2012
    Date of Patent: April 24, 2018
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Yunlong Zhang, Mark Schwartz
  • Patent number: 9936884
    Abstract: A system and method for treating hypotension in a mammal including a measuring device for measuring the blood pressure in a blood vessel having a wireless transmitter therein for emitting a signal when the measured blood pressure moves into a predetermined range. The system also includes an injection device fixed on the skin of a mammal, the injection device having a receiver for receiving the signal emitted from the wireless transmitter, a drug reservoir, a conduit for moving drug from the drug reservoir through the skin upon activation, and an activation device that causes the drug to move from the drug reservoir through the conduit and into the mammal upon receiving the signal emitted from the wireless transmitter.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: April 10, 2018
    Inventors: Megan Mikhail, Charlotte Anne Guertler
  • Patent number: 9936913
    Abstract: The present system is directed in various embodiments to devices, systems and methods for detection, evaluation and/or monitoring olfactory dysfunction by measuring and determining the patient's olfactory detection threshold for the left and the right nostril. More specifically, the present invention relates to devices, systems and methods for detecting an asymmetric differential in a patient's olfactory detection threshold (left vs right nostril) which, when present, may be used as a tool to screen, detect, diagnose and/or monitor relative olfactory deterioration resulting from Alzheimer's disease. A preferred embodiment comprises cascading aromas by serially administering more than one pure odorant to the patient's nostrils, left vs right, with measurement of the time, or numbers of breaths, required to cognitively notice the pure odorants' presence.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: April 10, 2018
    Assignee: Inspired Technologies, Inc.
    Inventor: Gregory B. Mills
  • Patent number: 9919123
    Abstract: The flow rate of a gaseous sample of exhaled breath through an analytical device is controlled by a pump, and in certain embodiments two pumps. Placement of the analyte sensor in a secondary stream branching off of the primary stream through the device offers further control over the manner, duration, and quantity of the breath that is placed in contact with the sensor.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: March 20, 2018
    Assignee: Circassia AB
    Inventors: Kevin Nason, Jonathan Fay, Bryan P. Flaherty, Bhairavi R. Parikh
  • Patent number: 9907500
    Abstract: The present invention is directed to membranes composed liquid crystals having continuous aqueous channels, such as a lyotropic liquid crystal, including a cubic phase lyotropic liquid crystal, and to electrochemical sensors equipped with such membranes. The membranes are useful in limiting the diffusion of an analyte to a working electrode in an electrochemical sensor so that the sensor does not saturate and/or remains linearly responsive over a large range of analyte concentrations. Electrochemical sensors equipped with membranes of the present invention demonstrate considerable sensitivity and stability, and a large signal-to-noise ratio, in a variety of conditions.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: March 6, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Adam Heller, Pawel Rowinski, Benjamin J. Feldman
  • Patent number: 9901288
    Abstract: Method for detecting gaseous component levels in a breath, comprising: receiving a breath through a breath channel, wherein the breath channel is in fluid communication with a flow rate sensor and an electrochemical fuel cell gas sensor; measuring a flow rate of the breath received through the breath channel; measuring a first time, wherein the first time corresponds to an amount of time elapsed while receiving the breath in the breath channel; and calculating a current gaseous component level utilizing the flow rate, first time and an output from the gas sensor. Methods for detecting an error condition while measuring gaseous component levels in a breath comprising: determining if the peak output occurs while breath is still being received in the breath channel; and if the peak output occurs while breath is still being received in the breath channel, alerting a user of an error condition.
    Type: Grant
    Filed: September 21, 2010
    Date of Patent: February 27, 2018
    Assignee: OmegaPoint Systems, LLC
    Inventor: Edward Gollar